Orthofix Medical CEO Mason to Retire, Serbousek Appointed Successor

Brad Mason, president and CEO of Orthofix Medical (NASDAQ: [[ticker:OFIX]]) since 2013, will retire on Oct. 31. The Lewisville, TX-based company has named Jon Serbousek his successor. Orthofix said Serbousek will serve as president of the company’s global spine business until Mason’s retirement. Serbousek comes to Orthofix from Pinnacle Advisory Partners, where he was managing general partner. His experience also includes positions at Biomet, Medtronic (NYSE: [[ticker:MDT]]), and Johnson & Johnson (NYSE: [[ticker:JNJ]]) subsidiary DePuy Orthopedics. Orthofix markets products for musculoskeletal applications.

Author: Frank Vinluan

Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times. View all posts by Frank Vinluan